210 related articles for article (PubMed ID: 20642852)
21. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE; Garcia RL
J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
[TBL] [Abstract][Full Text] [Related]
22. Uterine heterologous malignant mixed Müllerian tumor in a dwarf rabbit (Oryctolagus cuniculus).
Zadravec M; Gombač M; Račnik J; Zorman Rojs O; Pogačnik M; Švara T
J Vet Diagn Invest; 2012 Mar; 24(2):418-22. PubMed ID: 22379058
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
25. Malignant mixed mullerian tumor of the cervix including components of a rhabdomyosarcoma: case report and literature review.
Lee SH; Kim J; Kim JH; Lee KH; Park JS; Hur SY
Eur J Gynaecol Oncol; 2010; 31(4):462-6. PubMed ID: 20882897
[TBL] [Abstract][Full Text] [Related]
26. Malignant mixed müllerian tumors of the ovary.
Wei CF; Hwang SH; Ho CM; Shih BY; Chien TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):344-8. PubMed ID: 10820916
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
28. Ascitic fluid cytology of a malignant mixed Müllerian tumor of the peritoneum: a report of two cases with special reference to p53 status.
Kato N; Motoyama T
Diagn Cytopathol; 2009 Apr; 37(4):281-5. PubMed ID: 19217035
[TBL] [Abstract][Full Text] [Related]
29. [Two autopsy cases of malignant mixed müllerian tumor of the uterus with metastasis to alimentary tract and liver].
Sun M; Shioya T; Wang RJ; Ishiwata T; Naito Z; Qiao Y; Asano G; Ohaki Y; Kunimi T; Takeuchi T
Nihon Ika Daigaku Zasshi; 1995 Aug; 62(4):391-5. PubMed ID: 7559928
[TBL] [Abstract][Full Text] [Related]
30. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
[No Abstract] [Full Text] [Related]
32. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
Skomedal H; Kristensen GB; Lie AK; Holm R
Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
[TBL] [Abstract][Full Text] [Related]
34. Bilateral ovarian malignant mixed Mullerian tumor in a dog.
Antuofermo E; Cocco R; Borzacchiello G; Burrai GP; Meloni F; Bonelli P; Pirino S; Cossu-Rocca P; Bosincu L
Vet Pathol; 2009 May; 46(3):453-6. PubMed ID: 19176505
[TBL] [Abstract][Full Text] [Related]
35. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ; Khan R; Judd R
Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
[TBL] [Abstract][Full Text] [Related]
36. Mixed malignant mullerian tumor with neuroendocrine features in an irradiated uterus for cervical carcinoma. A unique association? A morphological, immunohistochemisty and ultrastructural study.
Vellone VG; Spina B; Grillo F; Calamaro P; Sarocchi F; Sala P; Ferrero S; Fulcheri E
Pathologica; 2017 Dec; 109(4):392-397. PubMed ID: 29449731
[TBL] [Abstract][Full Text] [Related]
37. p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.
Soong R; Knowles S; Hammond IG; Michael C; Iacopetta BJ
Cancer Detect Prev; 1999; 23(1):8-12. PubMed ID: 9892985
[TBL] [Abstract][Full Text] [Related]
38. Ovarian malignant Mullerian mixed tumor (heterologous) whose epithelial component is composed predominantly of signet ring cell carcinoma.
Terada T
Arch Gynecol Obstet; 2011 Jun; 283(6):1403-6. PubMed ID: 20652287
[TBL] [Abstract][Full Text] [Related]
39. Malignant mixed Mullerian tumor of the uterine cervix with neuroendocrine differentiation.
Ribeiro-Silva A; Novello-Vilar A; Cunha-Mercante AM; De Angelo Andrade LA
Int J Gynecol Cancer; 2002; 12(2):223-7. PubMed ID: 11975686
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
